Komori
Colopl (3668) · InitiativeRestated

Technology Research to Deliver New User Experiences

First written in FY2016-Q3. 31 of 32 entries say "Restated". Latest entry: FY2025.

32entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016-Q3 – FY20252016: 220162017: 420172018: 420182019: 420192020: 420202021: 320212022: 420222023: 320232024: 220242025: 22025
Same theme, other companies
Research and Development of Game Content and Game EnginesA theme 5 companies write about · 0 as a headwind · 5 as a tailwind

1 other company's latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2025RestatedAnnual report

    「In the entertainment business, the Company is conducting research into new technologies to deliver new user experiences alongside the development of new titles. Total R&D expenses for the current consolidated fiscal year were ¥1,503 million.」

    The disclosure reports the continuation of new title development and research into new technologies, as well as annual R&D expenses of ¥1,503 million.
  2. FY2025-H1RestatedAnnual report

    「Total R&D expenses for the current interim consolidated accounting period were ¥1,017 million. There were no material changes in the status of the Group's R&D activities during the current interim consolidated accounting period.」

    The disclosure reiterates that there were no material changes in R&D activities and discloses R&D expenses of ¥1,017 million for the current interim consolidated accounting period.
  3. FY2024-Q2RestatedAnnual report

    「Total R&D expenses for the second quarter of the current consolidated cumulative period were ¥1,276 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current consolidated cumulative period.」

    The disclosure reiterates that there were no material changes in R&D activities and reports R&D expenses of ¥1,276 million for the second quarter of the current consolidated cumulative period.
  4. FY2024-Q1RestatedAnnual report

    「Total R&D expenses for the first quarter of the current consolidated cumulative period were ¥592 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current consolidated cumulative period.」

    The disclosure reiterates that there were no material changes in R&D activities and reports R&D expenses of ¥592 million for the first quarter of the current consolidated cumulative period.
  5. FY2023-Q3RestatedAnnual report

    「Total R&D expenses for the third quarter of the current consolidated cumulative period were ¥1,810 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current consolidated cumulative period.」

    The disclosure reiterates that there were no material changes in R&D activities and reports R&D expenses of ¥1,810 million for the third quarter of the current consolidated cumulative period.
  6. FY2023-Q2RestatedAnnual report

    「Total R&D expenses for the second quarter of the current consolidated cumulative period were ¥1,113 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current consolidated cumulative period.」

    The disclosure reiterates that there were no material changes in R&D activities and reports R&D expenses of ¥1,113 million for the second quarter of the current consolidated cumulative period.
  7. FY2023-Q1RestatedAnnual report

    「Total R&D expenses for the first quarter of the current consolidated cumulative period were ¥551 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current consolidated cumulative period.」

    The disclosure reiterates that there were no material changes in R&D activities and reports R&D expenses of ¥551 million for the first quarter of the current consolidated cumulative period.
  8. FY2022RestatedAnnual report

    「The group has adopted the vision of “Delivering ‘new experiences’ through the latest technology and original ideas,” and, in its entertainment business, conducts research into new technologies and other activities to create new user experiences alongside the development of new titles. Total research and development expenses for the consolidated fiscal year amounted to ¥2,209 million.」

    Research into new technologies continued alongside new-title development, with annual research and development expenses of ¥2,209 million recorded.
  9. FY2022-Q3RestatedAnnual report

    「Total research and development expenses for the cumulative consolidated third quarter amounted to ¥1,605 million. There were no material changes in the status of the group’s research and development activities during the cumulative consolidated third quarter.」

    The absence of material changes in research and development activities is being restated, along with research and development expenses of ¥1,605 million.
  10. FY2022-Q2RestatedAnnual report

    「Total research and development expenses for the cumulative consolidated second quarter amounted to ¥996 million. There were no material changes in the status of the group’s research and development activities during the cumulative consolidated second quarter.」

    The absence of material changes in research and development activities is being restated, along with research and development expenses of ¥996 million.
  11. FY2022-Q1RestatedAnnual report

    「Total research and development expenses for the cumulative consolidated first quarter amounted to ¥459 million. There were no material changes in the status of the group’s research and development activities during the cumulative consolidated first quarter.」

    The absence of material changes in research and development activities is being restated, along with research and development expenses of ¥459 million for the quarter.
  12. FY2021-Q3RestatedAnnual report

    「Total research and development expenses for the cumulative consolidated third quarter amounted to ¥2,705 million. There were no material changes in the status of the group’s research and development activities during the cumulative consolidated third quarter.」

    The absence of material changes in research and development activities is being restated, along with research and development expenses of ¥2,705 million for the cumulative consolidated third quarter.
  13. FY2021-Q2RestatedAnnual report

    「Total research and development expenses for the cumulative consolidated second quarter amounted to ¥1,971 million. There were no material changes in the status of the group’s research and development activities during the cumulative consolidated second quarter.」

    The absence of material changes in research and development activities is being restated, along with research and development expenses of ¥1,971 million for the cumulative consolidated second quarter.
  14. FY2021-Q1RestatedAnnual report

    「Total research and development expenses for the cumulative consolidated first quarter amounted to ¥1,002 million. There were no material changes in the status of the group’s research and development activities during the cumulative consolidated first quarter.」

    The absence of material changes in research and development activities is being restated, along with research and development expenses of ¥1,002 million.
  15. FY2020RestatedAnnual report

    「Total research and development expenses for the consolidated fiscal year amounted to ¥3,402 million.」

    Research into new technologies continued, with research and development expenses of ¥3,402 million recorded for the consolidated fiscal year.
  16. FY2020-Q3RestatedAnnual report

    「Total research and development expenses for the cumulative consolidated third quarter amounted to ¥2,424 million. There were no material changes in the status of the group’s research and development activities during the cumulative consolidated third quarter.」

    The absence of material changes in research and development activities is being restated, along with research and development expenses of ¥2,424 million for the cumulative consolidated third quarter.
  17. FY2020-Q2RestatedAnnual report

    「Total research and development expenses for the cumulative consolidated second quarter amounted to ¥1,296 million. There were no material changes in the status of the group’s research and development activities during the cumulative consolidated second quarter.」

    The absence of material changes in research and development activities is being restated, along with research and development expenses of ¥1,296 million for the cumulative consolidated second quarter.
  18. FY2020-Q1RestatedAnnual report

    「Total research and development expenses for the cumulative consolidated first quarter amounted to ¥754 million. There were no material changes in the status of the group’s research and development activities during the cumulative consolidated first quarter.」

    The absence of material changes in research and development activities is being restated, along with research and development expenses of ¥754 million for the cumulative consolidated first quarter.
  19. FY2019RestatedAnnual report

    「In addition, alongside the development of new titles, we are conducting research into new technologies and other activities to create new user experiences. Total research and development expenses for the consolidated fiscal year amounted to ¥3,521 million.」

    Research into new technologies continued, with annual research and development expenses of ¥3,521 million recorded.
  20. FY2019-Q3RestatedAnnual report

    「Total research and development expenses for the cumulative consolidated third quarter amounted to ¥2,585 million. There were no material changes in the status of the group’s research and development activities during the cumulative consolidated third quarter.」

    The absence of material changes in research and development activities is being restated, along with research and development expenses of ¥2,585 million for the cumulative consolidated third quarter.
  21. FY2019-Q2RestatedAnnual report

    「Total research and development expenses for the cumulative consolidated second quarter amounted to ¥1,630 million. There were no material changes in the status of the group’s research and development activities during the cumulative consolidated second quarter.」

    The absence of material changes in research and development activities is being restated, along with research and development expenses of ¥1,630 million for the cumulative consolidated second quarter.
  22. FY2019-Q1RestatedAnnual report

    「Total research and development expenses for the cumulative consolidated first quarter amounted to ¥702 million. There were no material changes in the status of the group’s research and development activities during the cumulative consolidated first quarter.」

    The absence of material changes in research and development activities is being restated, along with research and development expenses of ¥702 million for the cumulative consolidated first quarter.
  23. FY2018RestatedAnnual report

    「In addition, alongside the development of new titles, we are conducting research into new technologies and other activities to create new user experiences. Total research and development expenses for the consolidated fiscal year amounted to ¥2,516 million.」

    Research into new technologies continued alongside new-title development, with annual research and development expenses of ¥2,516 million recorded.
  24. FY2018-Q3RestatedAnnual report

    「Total research and development expenses for the cumulative consolidated third quarter amounted to ¥1,663 million. There were no material changes in the status of the group’s research and development activities during the cumulative consolidated third quarter.」

    The absence of material changes in research and development activities is being restated, along with research and development expenses of ¥1,663 million for the cumulative consolidated third quarter.
  25. FY2018-Q2RestatedAnnual report

    「Total research and development expenses for the cumulative consolidated second quarter amounted to ¥1,077 million. There were no material changes in the status of the group’s research and development activities during the cumulative consolidated second quarter.」

    The absence of material changes in research and development activities is being restated, along with research and development expenses of ¥1,077 million for the cumulative consolidated second quarter.
  26. FY2018-Q1RestatedAnnual report

    「Total research and development expenses for the cumulative consolidated first quarter amounted to ¥542 million. There were no material changes in the status of the group’s research and development activities during the cumulative consolidated first quarter.」

    The absence of material changes in research and development activities is being restated, along with research and development expenses of ¥542 million for the cumulative consolidated first quarter.
  27. FY2017RestatedAnnual report

    「In addition, alongside the development of new titles, we are conducting research into new technologies and other activities to create new user experiences. Total research and development expenses for the consolidated fiscal year amounted to ¥2,684 million.」

    Research into new technologies continued alongside new-title development, with annual research and development expenses of ¥2,684 million recorded.
  28. FY2017-Q3RestatedAnnual report

    「In addition, alongside the development of new titles, we are conducting research into new technologies and other activities to create new user experiences. Total research and development expenses for the cumulative consolidated third quarter amounted to ¥2,067 million.」

    Research into new technologies continued alongside new-title development, with research and development expenses of ¥2,067 million recorded for the cumulative consolidated third quarter.
  29. FY2017-Q2RestatedAnnual report

    「In addition, alongside the development of new titles, we are conducting research into new technologies and other activities to create new user experiences. Total research and development expenses for the cumulative consolidated second quarter amounted to ¥1,379.404 million.」

    Research into new technologies continued alongside new-title development, with research and development expenses of ¥1,379.404 million recorded.
  30. FY2017-Q1RestatedAnnual report

    「In addition, alongside the development of new titles, we are conducting research into new technologies and other activities to create new user experiences. Total research and development expenses for the cumulative consolidated first quarter amounted to ¥590.610 million.」

    Research into new technologies continued alongside new-title development, with research and development expenses of ¥590.610 million recorded for the quarter.
  31. FY2016RestatedAnnual report

    「In addition, alongside the development of new titles, we are conducting research into new technologies and other activities to create new user experiences. Total research and development expenses for the consolidated fiscal year amounted to ¥2,913.300 million.」

    Research into new technologies continued, with research and development expenses of ¥2,913.300 million recorded.
  32. FY2016-Q3First statedAnnual report

    「In addition, alongside the development of new titles, we are conducting research into new technologies and other activities to create new user experiences. Total research and development expenses for the cumulative consolidated third quarter amounted to ¥2,240.383 million.」

    Research into new technologies continued alongside new-title development, with research and development expenses of ¥2,240.383 million recorded.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Colopl's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Technology Research to Deliver New User Experiences | COLOPL,Inc. (3668) | Komori